You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 23, 2025

Details for Patent: 9,566,244


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,566,244 protect, and when does it expire?

Patent 9,566,244 protects APTIOM and is included in one NDA.

This patent has thirty-three patent family members in twenty-two countries.

Summary for Patent: 9,566,244
Title:Pharmaceutical composition comprising licarbazepine acetate
Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
Inventor(s): Cardoso de Vasconcelos; Teofilo (S. Mamede do Coronado, PT), dos Santos Lima; Ricardo Jorge (S. Mamede do Coronado, PT), Cerdeira de Campos Costa; Rui (S. Mamede do Coronado, PT)
Assignee: BIAL-PORTELE & CA, S.A. (S. Mamede do Coronado, PT)
Application Number:14/108,615
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,566,244
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,566,244: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 9,566,244, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Understanding Patent 9,566,244

To begin, it is essential to identify the patent in question. United States Patent 9,566,244 is a utility patent that was granted on February 14, 2017. Here are the key elements to consider:

Inventors and Assignees

Identify the inventors and the assignees of the patent. This information is crucial for understanding the ownership and potential licensing or litigation issues[1].

Title and Abstract

The title and abstract provide a brief overview of the invention. This helps in understanding the core concept and the problem the invention aims to solve.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. There are two types of claims: independent and dependent. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[1].

Analyzing the Claims of Patent 9,566,244

Independent Claims

Independent claims are the broadest claims in the patent and define the invention in its most general form. For example, if Patent 9,566,244 is related to a technological innovation, the independent claims might describe the overall system or method.

Dependent Claims

Dependent claims narrow down the invention by adding specific limitations or features. These claims are often more detailed and can be used to differentiate the invention from prior art.

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis, also known as patent mapping, is a process that uses computer tools and human intelligence to analyze, organize, and extract value from vast amounts of patent data. This analysis helps in understanding the entire landscape of a technology domain and provides valuable insights into competitors and market trends[3].

Elements of Patent Landscape Analysis

  • Application Number, Filing Date, and Country: These details help identify the patent published in different countries and languages but referring to the same invention.
  • Legal Status: This includes the status of patents such as alive, pending, lapsed, revoked, or expired.
  • Expected Expiry Dates: Knowing when patents are expected to expire or lapse aids in decision-making.
  • Patent Trends and Market Developments: This includes mergers and acquisitions, in/out-licensing, litigation, and opposition activities[3].

Tools for Patent Search and Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art. It offers two modern interfaces that enhance access to patent information, replacing legacy tools like PubEast and PubWest[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This includes patent family information, classification, citation data, and office action indicators[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from IP5 Offices, allowing users to visualize search results for the same invention on a single page. This is part of the technical harmonization process aimed at integrating the global patent system[1].

Public Resources for Patent Analysis

Patent and Trademark Resource Centers (PTRCs)

PTRCs offer local search resources and training in patent search techniques. These centers are invaluable for individuals and businesses looking to conduct thorough patent searches[1].

USPTO Public Search Facility

Located in Alexandria, VA, the USPTO Public Search Facility provides access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[1].

Legal and Business Insights

Patent Allowance Rates

Understanding the probability of receiving a US patent is crucial. Studies have shown that the allowance rates vary based on factors such as the technology field, application origin, and entity size. For instance, the first-action allowance rate, progenitor allowance rate, and family allowance rate provide different perspectives on the likelihood of a patent being granted[4].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and serialized continuations, can significantly impact the patent examination process. These procedures allow applicants to continue the examination process, potentially leading to multiple patents from a single progenitor application[4].

Case Study: Analyzing Patent 9,566,244

To analyze Patent 9,566,244, one would need to:

Retrieve the Patent Document

Use the USPTO's Patent Public Search tool or other resources to retrieve the full text of the patent.

Identify Key Claims

Analyze the independent and dependent claims to understand the scope of the invention.

Conduct a Patent Landscape Analysis

Use tools like the Global Dossier and CCD to understand the broader patent landscape, including competitors and market trends.

Evaluate Legal Status and Expiry Dates

Check the legal status and expected expiry dates of the patent to assess its current and future impact.

Key Takeaways

  • Thorough Analysis: Conduct a detailed analysis of the claims and scope of the patent.
  • Use Advanced Tools: Utilize tools like Patent Public Search, Global Dossier, and CCD for comprehensive patent landscape analysis.
  • Legal and Business Insights: Understand patent allowance rates, continuation procedures, and their implications.
  • Public Resources: Leverage PTRCs and the USPTO Public Search Facility for additional support.

FAQs

Q: How do I search for a specific patent like 9,566,244?

A: You can use the USPTO's Patent Public Search tool or visit the USPTO Public Search Facility to search for specific patents.

Q: What is the importance of patent landscape analysis?

A: Patent landscape analysis helps in understanding the technology domain, identifying competitors, and gaining insights into market trends and legal, business, and technical information.

Q: How do continuation procedures affect the patent examination process?

A: Continuation procedures like RCEs and serialized continuations allow applicants to continue the examination process, potentially leading to multiple patents from a single progenitor application.

Q: Where can I find detailed information on patent allowance rates?

A: Studies and data from the USPTO, such as those analyzing allowance rates based on technology fields and application characteristics, provide detailed information on patent allowance rates.

Q: What resources are available for public patent searches?

A: Resources include the USPTO's Patent Public Search tool, Global Dossier, CCD, PTRCs, and the USPTO Public Search Facility.

Sources

  1. USPTO: Search for patents - USPTO.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. Sagacious Research: Navigating Technological Domains with Patent Landscape Analysis.
  4. Yale Journal of Law and Technology: What Is the Probability of Receiving a US Patent?
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,566,244

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-001 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-002 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-003 Nov 8, 2013 AB RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Sumitomo Pharma Am APTIOM eslicarbazepine acetate TABLET;ORAL 022416-004 Nov 8, 2013 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 4 of 4 entries

International Family Members for US Patent 9,566,244

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 069031 ⤷  Try for Free
Australia 2008317584 ⤷  Try for Free
Brazil PI0818680 ⤷  Try for Free
Canada 2703313 ⤷  Try for Free
European Patent Office 2214636 ⤷  Try for Free C02214636/01 Switzerland ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.